Table 3 12/24-month persistence rates and 95% confidence intervals (CI) for BTs psoriasis therapy

Number of patients

42

52

21

90

37

48

13

79

12-month persistence rate ± 95% CI

45.9% ± 15.5%

53.1% ± 14.7%

74.2% (95% CI not available)

79.8% ± 9.1%

46.8% ± 16.6%

53.0% ± 14.9%

55.4% (95% CI not available)

79.4% ± 9.9%

24-month persistence rate ± 95% CI

45.9 ± 15.5%

41.1% ± 15.4%

74.2% (95% CI not available)

73.4% ± 10.9%

46.8 ± 16.6%

41.0% ± 15.5%

55.4% (95% CI not available)

71.9 ± 12.2%

p-value of log-rank test (versus UST)

< 0.001

< 0.001

0.254

–

< 0.001

< 0.001

0.006

–

p-value of wilcoxon test (versus UST)

< 0.001

0.001

0.163

–

< 0.001

0.001

0.004

–